Index Option Calls
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Index Option Calls
No Result
View All Result
Home Latest News

Pfizer submits FDA application for emergency approval of Covid treatment pill

by
November 16, 2021
in Latest News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

New York identifies ‘disadvantaged communities’ that will receive extra climate funding

ChatGPT and A.I. might have a future as your portfolio manager, study suggests

Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021.

John Thys | Pool | Reuters

Pfizer on Tuesday submitted its application to the Food and Drug Administration for emergency authorization of its Covid-19 treatment pill, saying it reduces hospitalization and death by 89% when administered with a common HIV drug.

The pill, if authorized by the FDA, could help revolutionize the fight against Covid by allowing high-risk people infected with the virus to take an oral anti-viral drug at home instead of going to the hospital. Such a treatment could help reduce the strain that has been put on hospital systems during the pandemic.

In a clinical trial of people 18 and over at an increased risk of developing severe Covid, the pill reduced hospitalization and death by 89% when taken within three days of the onset of symptoms, according to Pfizer.

The pill, known as Paxlovid, blocks the activity of an enzyme the virus needs to replicate. Paxlovid is used in combination with a low-dose of ritonavir, an HIV drug, to slow the patient’s metabolism, allowing the drug to remain active in the body at a higher concentration for a longer period to combat the virus.

Pfizer said the Covid treatment proved to be safe, adding that there were fewer adverse events reported by trial participants who took Paxlovid than the placebo, and most of those were “mild in intensity.”

If approved, Paxlovid will be administered in two 150 mg tablets along with one 100 mg tablet of ritonavir twice daily.

“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application, along with other regulatory agencies around the world,” Pfizer CEO Albert Bourla said in a statement Tuesday.

Bourla had previously said that Pfizer planned to submit its data to the FDA before Thanksgiving.

Earlier Tuesday, Pfizer announced that it would allow generic manufacturers to supply its antiviral pill to 95 low and middle-income countries.

Merck is also developing an antiviral pill, Molnupiravir, to combat Covid. The company found in an interim analysis that the pill reduced the risk of hospitalization and death by 50% in adults with mild to moderate Covid.

Merck, which developed the drug with Ridgeback Biotherapeutics, submitted its application to the FDA last month for the pill to receive emergency authorization.

This is breaking news. Please Check back for updates.

ShareTweetPin

Related Posts

New York identifies ‘disadvantaged communities’ that will receive extra climate funding

by
March 29, 2023
0

People walk through the Brooklyn Bridge during a strike for climate on March 03, 2023 in New York City. Protesters...

ChatGPT and A.I. might have a future as your portfolio manager, study suggests

by
March 29, 2023
0

Lionel Bonaventure | Afp | Getty Images The proliferation of artificial intelligence programs such as ChatGPT and Alphabet's BardAI has...

Goldman Sachs picks the winners and losers in regional banks after the SVB collapse

by
March 29, 2023
0

The banking crisis continues to keep investors on edge about the health of regional banks. Now Goldman Sachs has identified...

We’re halfway to a tipping point for the Greenland Ice Sheet after which sea levels rise by 6 feet

by
March 29, 2023
0

An aerial view of meltwater lakes formed at the Russell Glacier front, part of the Greenland ice sheet in Kangerlussuaq,...

Elon Musk, tech leaders urge pause on ‘dangerous race’ to make A.I. as advanced as humans

by
March 29, 2023
0

Sopa Images | Lightrocket | Getty Images Elon Musk and dozens of other technology leaders have called on AI labs...

Next Post

Warren Buffett has been selling into this stock market rally for the past one year

November 16th COVID-19: New Cases Increasing, Above 83K per Day

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • A Couple Stored IRA Gold at Home. They Owe the IRS More Than $300,000.

    0 shares
    Share 0 Tweet 0
  • A California Couple Spent Eight Years Building Their Dream Retirement Home in Costa Rica

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs says buy these stocks to play Web 3.0 and the metaverse

    0 shares
    Share 0 Tweet 0
  • In his final warning, this stock trading wizard — who made big money in bear markets and crashes — called this market a bubble like no other

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs picks new stocks to buy — and says these 5 have over 100% upside

    0 shares
    Share 0 Tweet 0
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.indexoptioncalls.com
No Result
View All Result
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.indexoptioncalls.com